Carregant...
A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase
BACKGROUND: Vitamin K antagonists (VKAs), such as warfarin, have remained the cornerstone of oral anticoagulation therapy in the prevention and treatment of thromboembolism for over half a century. They function by impairing the biosynthesis of vitamin K-dependent (VKD) clotting factors through the...
Guardat en:
| Publicat a: | J Thromb Haemost |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7925372/ https://ncbi.nlm.nih.gov/pubmed/33314621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15209 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|